drugset / Trial / NCT04184908

Clinical Study New Gel for Xerostomia

NCT04184908 ↗

Phase 1 Unknown 60 enrolled Universidad de Murcia
RandomizedParallel-groupQuadruple-blindTreatment

Summary

At present, there is no single consensus protocol for the treatment of oral dryness, although the main objective is to improve the quality of life of patients. Current therapy for the control of xerostomia is based on the following measures: 1. General measures ; review and control of drugs,hydration and dietary advice: The main recommendations are found in the following scheme. 2. Saliva stimulants( Topics and sistemic )The option of using chewing stimuli by chewing gum with non-cariogenic sweeteners helps to improve symptoms. The investigators can also use gustatory stimuli, such as citric acid that is a potent stimulator of salivary secretion. Among the most commonly used pharmacological agents are: pilocarpine, bethanecol, civemiline 3. Saliva substitutes or artificial saliva. Saliva substitutes can provide a moisture retention layer in the oral mucosa and can be administered by liquids, spray, pills or gels. Topical treatments have few adverse effects and improve the quality of life of patients with xerostomia; In addition, they maintain oral health.

Timeline

Start
2019-10-01
Primary completion
2019-11-02
Completion
2020-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject gel xerostomia Unknown — Topical

Indications

No indication recorded.